Baillie Gifford & Co
ABMD

Baillie Gifford & Co’s Abiomed Inc ABMD Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,991
Closed -$1.14M 490
2022
Q4
$1.14M Sell
2,991
-3,621,946
-100% -$1.38B ﹤0.01% 270
2022
Q3
$891M Sell
3,624,937
-84,884
-2% -$20.9M 0.92% 31
2022
Q2
$918M Buy
3,709,821
+571
+0% +$141K 0.94% 30
2022
Q1
$1.23B Sell
3,709,250
-130,730
-3% -$43.3M 0.86% 28
2021
Q4
$1.38B Buy
3,839,980
+106,270
+3% +$38.2M 0.76% 34
2021
Q3
$1.22B Buy
3,733,710
+100,298
+3% +$32.6M 0.64% 40
2021
Q2
$1.13B Buy
3,633,412
+191,084
+6% +$59.6M 0.55% 46
2021
Q1
$1.1B Buy
3,442,328
+400,501
+13% +$128M 0.61% 43
2020
Q4
$986M Buy
3,041,827
+96,574
+3% +$31.3M 0.55% 46
2020
Q3
$816M Buy
2,945,253
+100,149
+4% +$27.7M 0.56% 42
2020
Q2
$687M Buy
2,845,104
+118,724
+4% +$28.7M 0.52% 41
2020
Q1
$396M Buy
2,726,380
+6,499
+0.2% +$943K 0.43% 51
2019
Q4
$464M Buy
2,719,881
+27,260
+1% +$4.65M 0.45% 55
2019
Q3
$479M Buy
2,692,621
+473,485
+21% +$84.2M 0.54% 47
2019
Q2
$578M Buy
2,219,136
+1,137,705
+105% +$296M 0.61% 37
2019
Q1
$309M Buy
1,081,431
+12,572
+1% +$3.59M 0.34% 69
2018
Q4
$347M Buy
1,068,859
+264,252
+33% +$85.9M 0.45% 59
2018
Q3
$362M Sell
804,607
-1,301,713
-62% -$585M 0.39% 59
2018
Q2
$862M Buy
2,106,320
+61,385
+3% +$25.1M 0.93% 24
2018
Q1
$595M Buy
2,044,935
+95,241
+5% +$27.7M 0.7% 32
2017
Q4
$365M Sell
1,949,694
-27,267
-1% -$5.11M 0.45% 51
2017
Q3
$333M Buy
1,976,961
+5,271
+0.3% +$889K 0.42% 55
2017
Q2
$283M Buy
1,971,690
+299,255
+18% +$42.9M 0.38% 58
2017
Q1
$209M Buy
1,672,435
+1,084,264
+184% +$136M 0.3% 67
2016
Q4
$66.3M Buy
588,171
+12,928
+2% +$1.46M 0.11% 88
2016
Q3
$74M Sell
575,243
-23,110
-4% -$2.97M 0.12% 83
2016
Q2
$65.4M Sell
598,353
-89,686
-13% -$9.8M 0.12% 86
2016
Q1
$65.2M Buy
688,039
+400,627
+139% +$38M 0.11% 89
2015
Q4
$25.9M Buy
+287,412
New +$25.9M 0.05% 101